JPWO2021038036A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021038036A5
JPWO2021038036A5 JP2022513059A JP2022513059A JPWO2021038036A5 JP WO2021038036 A5 JPWO2021038036 A5 JP WO2021038036A5 JP 2022513059 A JP2022513059 A JP 2022513059A JP 2022513059 A JP2022513059 A JP 2022513059A JP WO2021038036 A5 JPWO2021038036 A5 JP WO2021038036A5
Authority
JP
Japan
Prior art keywords
seq
sequence
immunoresponsive
region
binding element
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022513059A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022547416A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/074071 external-priority patent/WO2021038036A1/en
Publication of JP2022547416A publication Critical patent/JP2022547416A/ja
Publication of JPWO2021038036A5 publication Critical patent/JPWO2021038036A5/ja
Pending legal-status Critical Current

Links

JP2022513059A 2019-08-28 2020-08-28 B細胞標的化並列CAR(pCAR)治療的薬剤 Pending JP2022547416A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962892936P 2019-08-28 2019-08-28
US62/892,936 2019-08-28
US202062983451P 2020-02-28 2020-02-28
US62/983,451 2020-02-28
PCT/EP2020/074071 WO2021038036A1 (en) 2019-08-28 2020-08-28 B CELL TARGETED PARALLEL CAR (pCAR) THERAPEUTIC AGENTS

Publications (2)

Publication Number Publication Date
JP2022547416A JP2022547416A (ja) 2022-11-14
JPWO2021038036A5 true JPWO2021038036A5 (zh) 2023-09-04

Family

ID=72560541

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022513059A Pending JP2022547416A (ja) 2019-08-28 2020-08-28 B細胞標的化並列CAR(pCAR)治療的薬剤

Country Status (5)

Country Link
US (1) US20220298223A1 (zh)
EP (1) EP4021485A1 (zh)
JP (1) JP2022547416A (zh)
CN (1) CN114641308A (zh)
WO (1) WO2021038036A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201900858D0 (en) * 2019-01-22 2019-03-13 Price Nicola Kaye Receptors providing targeted costimulation for adoptive cell therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7446190B2 (en) 2002-05-28 2008-11-04 Sloan-Kettering Institute For Cancer Research Nucleic acids encoding chimeric T cell receptors
AU2013327136A1 (en) * 2012-10-02 2015-04-16 Memorial Sloan-Kettering Cancer Center Compositions and methods for immunotherapy
GB201513540D0 (en) 2015-07-31 2015-09-16 King S College London Therapeutic agents
CN108220247A (zh) * 2018-03-20 2018-06-29 杭州史迪姆生物科技有限公司 一种双car-t细胞及其制备方法和应用
CN109485732B (zh) * 2018-12-20 2021-09-24 四川大学华西医院 基因工程修饰的双靶点嵌合抗原受体及其用途

Similar Documents

Publication Publication Date Title
JP2020525032A5 (zh)
JP2020511152A5 (zh)
JP2022002546A (ja) 細胞
JP2009518050A5 (zh)
TW213486B (zh)
KR20180054590A (ko) 항글리피칸-3 항체 및 이의 응용
JP2009502171A5 (zh)
RU2018147423A (ru) Анти-PD-L1 и IL-2 цитокины
JP7104624B2 (ja) トランスフォーミング増殖因子ベータ応答性ポリペプチド及びその使用方法
JP2023139070A5 (zh)
JP2018519263A5 (zh)
JP2020512019A5 (zh)
JP2018512170A5 (zh)
JP2017509643A5 (zh)
JP2019521169A5 (zh)
JP2018532407A5 (zh)
JP2021503006A5 (zh)
JPWO2019129221A5 (zh)
JPWO2019215500A5 (zh)
JP2018528776A5 (zh)
CN114502591B (zh) 靶向bcma的抗体、双特异性抗体及其用途
JPWO2021108613A5 (zh)
KR20240037892A (ko) 클라우딘 18.2 t 세포-항원 커플러 및 이의 용도
WO2022033057A1 (zh) 一种基于单域抗体的bcma嵌合抗原受体及其应用
CN103897057A (zh) 多价抗体片段与其三聚复合物